ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application 61/054,709, filed May 20, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,691,531 | ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use In force · Medium confidence | Genentech, Inc. | In force | Medium confidence | ||
| US 9,896,506 | ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use In force · Low confidence | Genentech, Inc. | In force | Low confidence | ||
| US 10,494,432 | ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use In force · Medium confidence | Genentech, Inc. | In force | Medium confidence | ||
| US 10,544,218 | ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use In force · Medium confidence | Genentech, Inc. | In force | Medium confidence | ||
| US RE48,558 | ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use In force (reinstated) · Low confidence | Genentech, Inc. | In force (reinstated) | Low confidence | ||
| US 8,722,857 | ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use In force · High confidence | Genentech, Inc. | In force | High confidence | ||
| US 8,088,378 | ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use In force · High confidence | Genentech, Inc. | In force | High confidence | ||
| US 8,545,850 | ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use Surrendered on reissue May 18, 2021 Surrendered on reissue May 18, 2021 · Low confidence | Genentech, Inc. | Surrendered on reissue May 18, 2021 | Surrendered on reissue May 18, 2021 | Low confidence | |
| Application 14/219,473 | ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use Abandoned Abandoned Nov 14, 2016 | Genentech, Inc. | Abandoned | Abandoned Nov 14, 2016 | ||
| Application 16/600,331 | ANTI-CD79B Antibodies and Immunoconjugates and Methods of Use Abandoned Abandoned Sep 7, 2022 | Genentech, Inc. | Abandoned | Abandoned Sep 7, 2022 | ||
| 4 more patents in this group · Pro | ||||||
10 of 14 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 14, including 1 expired.
7 of these are in force and held by Genentech, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.